The biotech-verse was buzzing this week after Kite Pharma Inc (NASDAQ:KITE) submitted an IND application for its pipeline cancer drug that sent shares rising. …
In a research report released Thursday, FBR analyst Edward White reiterated an Outperform rating on shares of Juno Therapeutics Inc (NASDAQ:JUNO) with a price …
Yesterday, Kite Pharma Inc (NASDAQ:KITE) announced positive top-line interim results from its ZUMA-1 pivotal trial in patients with aggressive Non-Hodgkin’s lymphoma (NHL). At …
On Tuesday morning, Synthetic Biologics Inc (NYSEMKT:SYN) made a positive stride with the completion of an End of Phase 2 meeting with the FDA for …
In a research report issued Friday, FBR analyst Edward White reiterated an Outperform rating on shares of Synthetic Biologics Inc (NYSEMKT:SYN), with a price …
In a research report released Friday, FBR analyst Edward White initiated coverage on shares of Synthetic Biologics Inc (NYSEMKT:SYN), with an Outperform rating …
In a research report released today, FBR Capital analyst Edward White initiated coverage on shares of Kite Pharma Inc (NASDAQ:KITE) with a price target of …